Dr. Edward Margolin

Dr. EDWARD MARGOLIN completed a residency in ophthalmology at McGill Faculty of Medicine. He then completed a neuro-ophthalmology fellowship at the University of Michigan. Currently he is a Full Professor at the Department of Ophthalmology and Visual Sciences and Department of Neurology at the University of Toronto Faculty of Medicine. He is also a Director of Neuro-Ophthalmology/Adult Strabismus Fellowship at the University of Toronto.  

Since coming to Toronto in 2007, Dr. Margolin has established a very active clinical practice in comprehensive ophthalmology and neuro-ophthalmology. After five years of full time practice at Mount Sinai Hospital, Dr. Margolin has moved his practice to TESS. He performs cataract surgery at Kensington Eye Institute and adult strabismus surgery at Mount Sinai Hospital. Dr. Margolin is on staff at Mount Sinai Hospital and Toronto Western Hospital. He has been teaching ophthalmology and neurology trainees at all levels as well as participating in a variety of neuro-ophthalmology educational programs for the Department of Internal Medicine, Emergency Medicine, and Family Medicine.  

In 2011 and then again in 2015 Dr. Margolin was awarded the Best Teacher in Ophthalmology Award. In 2013 and then again in 2021 he was nominated and awarded the Wightman-Berris Academy Individual Teaching Performance Award. In 2017 Dr. Margolin received J. S. Crawford Teaching Award (Most Popular Teacher) and in 2018 he was a recipient of the Professional Association of Residents of Ontario Excellence in Clinical Teaching Award (awarded to 2 physicians at the University of Toronto yearly). In 2021 he was awarded the Distinguished Educator Award at Mount Sinai Hospital. 

Dr. Margolin has published over 180 peer-reviewed articles and given multiple lectures nationally and internationally. He has been actively involved in North American Neuro-Ophthalmological Society where he sits on several committees.   

His research endeavors are focused on understanding the mechanisms and looking for a treatment for non-arteritic anterior ischemic optic neuropathy and understanding pathophysiology and best treatment practices for patients with idiopathic intracranial hypertension. He is a clinical lead at the Kensington Eye Institute in a large multi-center collaborative research project investigating the relationship between the quantitative levels of beta-amyloid protein in crystalline lens and development of Alzheimer’s disease.